首页> 外国专利> A NEW METHOD FOR QUANTITATIVE ASSESSMENT OF P-GLYCOPROTEIN-RELATED MULTIDRUG RESISTANCE IN TUMOR CELLS

A NEW METHOD FOR QUANTITATIVE ASSESSMENT OF P-GLYCOPROTEIN-RELATED MULTIDRUG RESISTANCE IN TUMOR CELLS

机译:肿瘤细胞中与P-糖蛋白相关的多药耐药性定量评估的新方法

摘要

the object of the invention is a quantitative analysis in a broad vitru0151 diagnu0151sztikaielju00e1ru00e1s daganatu0151k (mu0171ltidru0151g - resistance (mdr) u0151ku0151zu00f3transzpu0151rtfehu00e9rje - protein) activity, and the test mintabiu0151lu00f3giailag active fehu00e9rjeku0151ncentru00e1ciu00f3ju00e1nak meghatu00e1ru0151zu00e1su00e1ra. atalu00e1lmu00e1ny are subject to an implementation of the procedure szu0151lgu00e1lu00f3 reagent kits.the invention is in accordance with the procedure of the test biu0151lu00f3giaimintu00e1t or a part of a good u0151lyanszu00e1rmazu00e9ku00e1val u00e9rintkeztetik detectable compound, which is the transzpu0151rtfehu00e9rje szu0171bsztru00e1tja,the cells can beju0171tni inside cells, and an enzyme (s) of u0151lyan alaku0171lni well detectable compound, which is not atranszpu0151rtfehu00e9rju00e9nek szu0171bsztru00e1tja, and the felhalmu0151zu00f3dik cells.some kind of measurement (pu00e9ldu00e1u0171l flu0171u0151reszcencia or fu00e9nyabszu0151rpciu00f3) is characterised by the cells of the kvantitatu00edvan u00e1talaku0171lt vegyu00fcletfelhalmu0151zu00f3du00e1su00e1nak speedthen the test sample in the presence of biu0151lu00f3giai, another part of the ju00f3ldetektu00e1lhatu00f3 szu00e1rmazu00e9ku00e1val transzpu0151rtblu0151kku0151lu00f3 u00e9rintkeztetik compound, and azu0151nu0151s mu00f3du0151n,the cells of the kvantitatu00edvanjellemzik u00e1talaku0171lt compound felhalmu0151zu00f3du00e1su00e1naksebessu00e9gu00e9t,on the basis of the measured values, and the relationships empiriku0171s respectto diagnu0151sztikai unit shall provide the sample talu00e1lhatu00f3biu0151lu00f3giailag active mdr protein activity and / or ku0151ncentru00e1ciu00f3ju00e1t.in accordance with the procedure atalu00e1lmu00e1ny and reagensku00e9szletek, alkalmazhatu00f3kelsu0151su0151rban hu0171mu00e1n clinical labu0151ratu00f3riu0171mi diagnu0151sztiku00e1ban,the rates of tu0171mu0151ru0151sdaganatu0151k mu0171ltidru0151grezisztencia mdr activity alapju00e1ntu00f6rtu00e9nu0151 gyu0151rs and simple estimation, which is a big help kemu0151teru00e1piu00e1s respectto beavatku0151zu00e1s pu0151ntu0151s design. a
机译:发明内容本发明的目的是在广泛的玻璃中定量分析daganat u0151k(m u0171ltidr u0151g-抗性(mdr) u0151k u0151z u00f3transzp u0151rtfeh ,并且测试了mintabi u0151l u00f3giailag活动feh u00e9rjek u0151ncentr u00e1ci u00f3j u00e1nak meghat u00e1r u0151z u00e1s u00e1ra。 atal u00e1lm u00e1ny需执行sz u0151lg u00e1l u00f3试剂盒的程序。本发明符合测试bi u0151l u00f3giaimint u00e1t的程序或好的 u0151lyansz 的一部分u00e1rmaz u00e9k u00e1val u00e9rintkeztetik可检测化合物,即transzp u0151rtfeh u00e9rje sz u0171bsztr u00e1tja,细胞可以在细胞内被检测,并且可以检测到 u0171酶(s)不是atranszp u0151rtfeh u00e9rj u00e9nek和felhalm u0151z u00f3dik单元格。某种类型的测量(p u00e9ld u00e1 u0171l fl u0171 u11 u1 u1 u1 u1 u1 u1 u1 u1 u1 u1 u1 u11 u0151res它的特征是kvantitat u00edvan u00e1talak u0171lt vegy u00fcletfelhalm u0151z u00f3d u00e1s u00e1nak的速度加快,然后在bi u0151l u00f3giai存在的情况下测试样品sz u00e1rmaz u00e9k u00e1val transzp u0151rtbl u0151kk u015 1l u00f3 u00e9rintkeztetik化合物和az u0151n u0151s m u00f3d u0151n,kvantitat u00edvanjellemzik u00e1talak u0171lt化合物felhalm u0151z u00f1d u00s e00 9 n00 n00 1测量值,以及与诊断单元有关的关系,应按照程序为样品tal / u00f1bhat u00f3bi u0151l u00f3giailag活性mdr蛋白活性和/或k u0151ncentr u00e1ci u00f3j u00e3t提供依据。 atal u00e1lm u00e1ny和reagensk u00e9szletek,alkalmazhat u00f3kels u0151s u0151rban h u0171m u00e1n临床实验室 u0151rat u00f3ri u0171mi diagn u0151m ban u0151m an u0151t u0171ltidr u0151grezisztencia mdr活动alapj u00e1nt u00f6rt u00e9n u0151 gy u0151rs和简单的估算,对于beavatk u0151z u00s1设计来说,这是一个很大的帮助。一种

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号